BIIB vs BMY
Biogen vs Bristol Myers Squibb — AI-powered side-by-side comparison
| Metric | BIIB | BMY |
|---|---|---|
| AI Score | 59 | 55 |
| Price | $197.66 | $60.77 |
| P/E Ratio | 21.68× | 17.12× |
| ROE | 0.1% | 0.4% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.7% |
| Debt / Equity | 0.35× | 2.22× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 50.0 | 65.0 |
| Beta | 0.158 | 0.235 |
| Expected Upside | +1.3% | +0.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BIIB Full Analysis
BMY Full Analysis